欢迎登录材料期刊网

材料期刊网

高级检索

氧氟沙星在眼科临床广泛应用,本研究以氧氟沙星作为模型药物,采用水/油/水(w/o/w)的复乳化和溶剂扩散技术制备氧氟沙星聚乳酸-聚乙醇酸(PLGA)微囊,对影响包封率的工艺参数如药物浓度、PLGA使用量、初乳复乳的搅拌速率进行研究,并对微囊的粒径、表面电位和表面形态的理化性能进行了表征.测试结果表明,根据优化工艺制备的氧氟沙星PLGA微囊的平均粒径511.9±14.6nm,zeta电位-17.97±0.80mV,包封率54.2%,载药量1.94%.包封率随PLGA使用量、初乳搅拌速率的增加而上升,随内水相药物体积和浓度的增加而下降.通过优化的水/油/水(w/o/w)复乳化和溶剂扩散技术制备氧氟沙星PLGA载药微囊的粒度分布窄,载药量和包封率适中,具有较好的临床应用前景.

参考文献

[1] Dillen K;Vandervoort J;Van den Mooter G;Verheyden L;Ludwig A .Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles.[J].International Journal of Pharmaceutics,2004(1/2):171-187.
[2] Dillen K;Vandervoort J;Van den Mooter G;Ludwig A .Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.[J].International Journal of Pharmaceutics,2006(1):72-82.
[3] Gavini E;Chetoni P;Cossu M;Alvarez MG;Saettone MF;Giunchedi P .PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: in vitro/in vivo studies.[J].European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V,2004(2):207-212.
[4] Teixeira M;Alonso MJ;Pinto MM;Barbosa CM .Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone.[J].European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V,2005(3):491-500.
[5] Ito F;Fujimori H;Makino K .Factors affecting the loading efficiency of water-soluble drugs in PLGA microspheres[J].Colloids and Surfaces, B. Biointerfaces,2008(1):25-29.
[6] Govender T;Garnett MC;Illum L;Davis SS;Stolnik S .PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug.[J].Journal of Controlled Release: Official Journal of the Controlled Release Society,1999(2):171-185.
上一张 下一张
上一张 下一张
计量
  • 下载量()
  • 访问量()
文章评分
  • 您的评分:
  • 1
    0%
  • 2
    0%
  • 3
    0%
  • 4
    0%
  • 5
    0%